Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci

  • 1, 13, 14Email author,
  • 2,
  • 3,
  • 4, 5,
  • 6,
  • 7,
  • 4, 5,
  • 6,
  • 8,
  • 9 and
  • 10, 11, 12
Clinical EpigeneticsThe official journal of the Clinical Epigenetics Society20168:27

https://doi.org/10.1186/s13148-016-0194-5

  • Received: 1 March 2016
  • Accepted: 1 March 2016
  • Published:

The original article was published in Clinical Epigenetics 2015 7:123

Erratum

Unfortunately, after publication of the original version of this article [1], it was noticed that there were some errors in Fig. 3 and Fig. 4:
  • In Fig. 3, the methylation of H19/IGF2:IG-DMR hypomethylation is not correctly illustrated: the lolly pops should be empty (=unmethylated).

  • In Fig. 4, the methylation of both H19/IGF2:IG-DMR hypermethylation and KCNQ1OT1:TSS-DMR hypomethylation are not correctly illustrated: in case of the H19/IGF2:IG-DMR hypermethylation the lolly pops should be filled (=methylated), and for the KCNQ1OT1:TSS-DMR, they should be empty (=unmethylated).

The corrected Fig. 3 and Fig. 4 have been included in this erratum.
Fig. 3
Fig. 3

The 11p15.5 cluster can be divided in two functional domains whose imprinting is dependent on distinct imprinting control regions (H19/IGF2: IG DMR and KCNQ1OT1: TSS DMR). Mainly hypomethylation of the KCNQ1OT1: TSS DMR is responsible for SRS

Fig. 4
Fig. 4

Epimutations and mutations in 11p15.5 are also responsible for BWS

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Human Genetics, RWTH Aachen, Pauwelsstr. 30, Aachen, Germany
(2)
Molecular (Epi)Genetics Laboratory, BioAraba National Health Institute, Hospital Universitario Araba, Vitoria-Gasteiz, Spain
(3)
Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK
(4)
Human Genetics and Genomic Medicine, Faculty of Medicine University of Southampton, Southampton, UK
(5)
WessexClinical Genetics Service, Princess Anne Hospital, Coxford Road, Southampton, UK
(6)
Clinical Genetic Clinic, Kennedy Center, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark
(7)
Imprinting and Cancer Group, Cancer Epigenetic and Biology Program (PEBC), Institut d’Investigació Biomedica de Bellvitge (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain
(8)
DiSTABiF, Seconda Università degli Studi di Napoli, Caserta, Italy
(9)
Institute of Genetics and Biophysics—ABT, CNR, Napoli, Italy
(10)
Endocrinology and diabetology for children and reference center for rare disorders of calcium and phosphorus metabolism, Bicêtre Paris Sud, APHP, Le Kremlin-Bicêtre, France
(11)
INSERM U986, INSERM, Le Kremlin-Bicêtre, France
(12)
INSERM, UMR_S 938, CDR Saint-Antoine, Paris, F-75012, France
(13)
Sorbonne Universites, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, Paris, France
(14)
3APHP, Pediatric Endocrinology, Armand Trousseau Hospital, Paris, France

Reference

  1. Eggermann T, Perez de Nanclares G, Maher ER, Temple IK, Tümer Z, Monk D, et al. Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci. Clin Epigenetics. 2015;7:123. doi:10.1186/s13148-015-0143-8.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Eggermann et al. 2016

Advertisement